TNM-7th edition 2009 (UICC/AJCC) and Japanese Classification 2010 in Gastric Cancer. Towards simplicity and standardisation in the management of gastric cancer;TNM 7.a edición 2009 (UICC/AJCC) y Clasificación Japonesa 2010 en Cáncer Gástrico. Hacia la simplicidad y estandarización en el manejo del cáncer gástrico

Cirugia Espanola

Volumn 89, Issue 5, 2011, Pages 275-281

  Rodríguez Santiago, Joaquín M ^a   Sasako, Mitsuru ^b   Osorio, Javier ^a  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Gastric cancer; Japanese classification 2010; Lymphadenectomy; TNM (7th edition)

Indexed keywords

ARTICLE; CANCER STAGING; CLASSIFICATION; HUMAN; JAPAN; PATHOLOGY; PRACTICE GUIDELINE; STOMACH TUMOR;

HUMANS; JAPAN; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; STOMACH NEOPLASMS;

EID: 79955126577     PISSN: 0009739X     EISSN: 1578147X     Source Type: Journal    
DOI: 10.1016/j.ciresp.2010.10.011     Document Type: Article

References (22)

1. TNM classification of malignant tumours 2002, International Union Against Cancer, Wiley-Liss, New York. 6th edn. L.H. Sobin, C.H. Wittekind (Eds.).
2. AJCC Cancer Staging Manual. 7th edition. Springer, New York, NY: 2010.
3. Japanese classification of gastric carcinoma. 2nd English edition. Gastric Cancer. 1998, 1:25-30. Japanese Gastric Cancer Association.
4. Sano T. Evaluation of the gastric cancer treatment guidelines of the Japanese Gastric Cancer Association. Gan to Kagaku Ryoho. 2010, 37:582-586.
5. Bollschweiler E, Mönig S, Schulte C, Hölscher A. TNM-Classification 2009: The prognostic relevance of the new pN-category in gastric cancer. En: 8th IGCC. Krakow, Poland. 2009, June 10-13 (Abstract S54).
6. Ahn H.S., Lee H.J., Hahn S., Kim W.H., Lee K.U., Sano T., et al. Evaluation of the Seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification. Cancer. 2010 Aug 24, [Epub ahead of print].
7. Schwarz R.E., Smith D.D. Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage. Ann Surg Oncol. 2006, 14:317-328.
8. Rodríguez Santiago J.M., Muñoz E., Martí M., Quintana S., Veloso E., Marco C. Metastatic lymph node ratio as a prognostic factor in gastric cancer. Eur J Surg Oncol. 2005, 31:59-66.
9. Siewert J.R., Feith M., Werner M., Stein H.J. Adenocarcinoma of the esophagogastric junction:results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg. 2000, 232:353-361.
10. Noguchi Y., Imada T., Matsumoto A., Coit D.G., Brennan M.F. Radical surgery for gastric cancer:a review of the Japanese experience. Cancer. 1989, 64:2053.
11. Sasako M., McCulloch P., Kinoshita T., Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995, 82:346-351.
12. Adachi Y., Kamakura T., Mori M., Baba H., Maehara Y., Sugimachi K. Prognostic significance of the number of positive nodes in gastric carcinoma. Br J Surg. 1994, 81:414-416.
13. Kunisaki C., Shimada H., Nomura M., Matsuda G., Otsuka Y., Ono H., et al. Comparative evaluation of gastric carcinoma staging:Japanese classification versus new American joint committee on cancer/international union against cancer classification. Ann Surg Oncol. 2004, 11:203-206.
14. Yamasawa N.Y., Yamaguchi K., Itakura M., Omori H., Koike M., Kitamura Y., et al. Problems in the N-classification of the new 1997 UICC TNM stage classification for gastric cancer:an analysis of over 10 years' outcome of Japanese patients. Anticancer Res. 2003, 23(1B):697-705.
15. Huang B., Zhang X., Wang Z., Wang M., Dong Y., Zhao Y., et al. Prognostic significance of the number of metastatic lymph nodes:Is UICC/TNM Node classification perfectly suitable for early gastric cancer?. Ann Surg Oncol. 2009, 16:61-67.
16. Sano T. New Japanese Classification and treatment guidelines incorporating new UICC/TNM Classification. En: 8th IGCC. Krakow, Poland. 2009, June 10-13 (EUNE Sessions- Abstract 5).
17. Sano T., Sasako M., Yamamoto S., Nashimoto A., Kurita A., Hiratsuka M., et al. Gastric cancer surgery:morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group study 9501. J Clin Oncol. 2004, 22:2767-2773.
18. Sasako M., Sano T., Yamamoto S., Kurokawa Y., Nashimoto A., Kurita A., et al. D2 lymphadenectomy alone or with para-aortic nodal idssection for gastric cancer. N Engl J Med. 2008, 359:453-462. Japan Clinical Oncology Group.
19. Sano T., Yamamoto S., Sasako M. Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma: Japan clinical oncology group study JCOG 0110-MF. Jpn J Clin Oncol. 2002, 32:363-364. Japan Clinical Oncology Group Study LCOG 0110-MF.
20. Sano T, Sasako M, Shibata T, Yamamoto S, Tsuburaya A, Nashimoto A, et al., Japan Clinical Oncology Group. Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma (JCOG0110): Analyzes of operative morbidity, operation tima and bood loss. J Clin Oncol. 2010; 28:15s, (suppl;abstr 4020).
21. Sakuramoto S., Sasako M., Yamaguchi T., Kinoshita T., Fujii M., Nashimoto A., et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007, 357:1810-1820. ACTS-GC Group.
22. Paoletti X., Oba K., Burzykowski T., Michiels S., Ohashi Y., Pignon J.P., et al. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA. 2010, 303:1729-1737. GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group.